Mrs. Alexandra Diane Janet Mancini - 02 Jun 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role: Sr VP, Clinical Reg Affairs
Signature: /s/ Brenda Edwards, attorney-in-fact for Mrs. Alexandra Diane Janet Mancini
Issuer symbol: INM
Transactions as of: 02 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Jun 2022, 14:51:10 UTC
Previous filing: 23 Feb 2022
Next filing: 18 Nov 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INM	Employee Stock Option (Expiration)	Expiration (or cancellation) of long derivative position with value received	$0	-1,515	-1.5%	$0.000000	98,787	02 Jun 2022	Common shares	1,515	$11.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Converted from the Canadian dollar exercise price of C$14.85 using an exchange rate of C$1.2639 = $US1.00